Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

BGV (BioGeneration Ventures)

Status
ACTIVE
Global HQ
Zaandam, Netherlands
Countries of investment
  • Germany
  • United Kingdom
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Health Tech
  • Enterprise
  • Financial Services
  • Deep Tech
About
BioGeneration Ventures (BGV) is a venture Capital firm specializing in early stage life sciences investments. They leverage extensive sector expertise and a robust network to support the growth of innovative biotech companies across Europe.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

BioGeneration Ventures focuses on early stage life sciences companies, investing in biopharma, BioTech, drug discovery, and development. They aim to transform innovative research into successful commercial ventures, emphasizing Sustainability and significant societal impact.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Artica Therapeutics

Azafaros

Brenig

Catalym

Citryll

Complement Therapeutics

Confo Therapeutics

Dualyx

Dunad

Fibrocor

FundaMental Pharma

Genase Therapeutics

Mironid

NorthSea Therapeutics

Phlox

Phosphoenix

RhyGaze

Scenic Biotech

Tessellate Bio

Tiga Tx

VarmX

VectorY

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp